Targeted Therapies in Adult B-Cell Malignancies

Por Rossi, Jean-François
Publicado no Biomed Res Int (2015)

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence

Por Trikha, Mohit, Corringham, Robert, Klein, Bernard, Rossi, Jean-François
Publicado em 2003

γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

Por Braza, Mounia Sabrina, Klein, Bernard, Fiol, Geneviève, Rossi, Jean-François
Publicado em 2011

Evaluation of Endometrial Inflammation by Quantification of Macrophages, T Lymphocytes, and Interleukin-1 and -6 in Human Endometrium

Por Déchaud, Hervé, Maudelonde, Thierry, Daurès, Jean Pierre, Rossi, Jean François, Hédon, Bernard
Publicado em 1998

Tumor necrosis factor is a survival and proliferation factor for human myeloma cells

Por Jourdan, Michel, Tarte, Karin, Legouffe, Eric, Brochier, Jean, Rossi, Jean-François, Klein, Bernard
Publicado em 1999

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma

Por Kassambara, Alboukadel, Hose, Dirk, Moreaux, Jérôme, Rème, Thierry, Torrent, Jennifer, Rossi, Jean François, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2012

An inhibitor of the EGF receptor family blocks myeloma cell growth factor activity of HB-EGF and potentiates dexamethasone or anti-IL-6 antibody-induced apoptosis

Por Mahtouk, Karène, Jourdan, Michel, De Vos, John, Hertogh, Catherine, Fiol, Geneviève, Jourdan, Eric, Rossi, Jean-François, Klein, Bernard
Publicado em 2004

Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma: results of a phase II study

Por Cartron, Guillaume, Zhao-Yang, Lu, Baudard, Marion, Kanouni, Tarik, Rouillé, Valérie, Quittet, Philippe, Klein, Bernard, Rossi, Jean-Francois
Publicado em 2008

Insulin is a potent myeloma cell growth factor through insulin/IGF-1 hybrid receptor activation

Por Sprynski, Anne Catherine, Hose, Dirk, Kassambara, Alboukadel, Vincent, Laure, Jourdan, Michel, Rossi, Jean-François, Goldschmidt, Harmut, Klein, Bernard
Publicado em 2010

High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma

Por SAIFI, MAJDA, MARAN, AURÉLIE, RAYNAUD, PIERRE, PICOT, MARIE CHRISTINE, QUITTET, PHILIPPE, CARTRON, GUILLAUME, ROSSI, JEAN FRANÇOIS, COSTES, VALÉRIE
Publicado em 2010

B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro

Por Lu, Zhao-Yang, Condomines, Maud, Tarte, Karin, Nadal, Laure, Delteil, Marie-Claude, Rossi, Jean-François, Ferrand, Christophe, Klein, Bernard
Publicado em 2007

Survival and proliferation factors of normal and malignant plasma cells

Por Klein, Bernard, Tarte, Karin, Jourdan, Michel, Mathouk, Karene, Moreaux, Jerome, Jourdan, Eric, Legouffe, Eric, De Vos, John, Rossi, Jean François
Publicado em 2003

Input of DNA microarrays to identify novel mechanisms in multiple myeloma biology and therapeutic applications

Por Mahtouk, Karène, Hose, Dirk, De Vos, John, Moreaux, Jérôme, Jourdan, Michel, Rossi, Jean François, Rème, Thierry, Goldschmidt, Harmut, Klein, Bernard
Publicado em 2007

Gene expression of anti- and pro-apoptotic proteins in malignant and normal plasma cells

Por Jourdan, Michel, Rème, Thierry, Goldschmidt, Harmut, Fiol, Geneviève, Pantesco, Véronique, De Vos, John, Rossi, Jean-François, Hose, Dirk, Klein, Bernard
Publicado em 2009

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

Por Moreaux, Jérôme, Legouffe, Eric, Jourdan, Eric, Quittet, Philippe, Rème, Thierry, Lugagne, Cécile, Moine, Philippe, Rossi, Jean-François, Klein, Bernard, Tarte, Karin
Publicado em 2004

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

Por Mahtouk, Karène, Moreaux, Jérôme, Hose, Dirk, Rème, Thierry, Meißner, Tobias, Jourdan, Michel, Rossi, Jean François, Pals, Steven T, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2010

Increased plasma-immune cytokines throughout the high-dose melphalan-induced lymphodepletion in patients with multiple myeloma: a window for adoptive immunotherapy

Por Condomines, Maud, Veyrune, Jean-Luc, Larroque, Marion, Quittet, Philippe, Latry, Pascal, Lugagne, Cécile, Hertogh, Catherine, Kanouni, Tarik, Rossi, Jean-François, Klein, Bernard
Publicado em 2010

Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells

Por Bret, Caroline, Hose, Dirk, Reme, Thierry, Sprynski, Anne-Catherine, Mahtouk, Karène, Schved, Jean-François, Quittet, Philippe, Rossi, Jean-François, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2009

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Por Caraux, Anouk, Vincent, Laure, Bouhya, Salahedine, Quittet, Philippe, Moreaux, Jérôme, Requirand, Guilhem, Veyrune, Jean-Luc, Olivier, Gaëlle, Cartron, Guillaume, Rossi, Jean-François, Klein, Bernard
Publicado no Oncotarget (2012)

Microarray-based understanding of normal and malignant plasma cells

Por De Vos, John, Hose, Dirk, Rème, Thierry, Tarte, Karin, Moreaux, Jérôme, Mahtouk, Karéne, Jourdan, Michel, Goldschmidt, Hartmut, Rossi, Jean-François, Cremer, Friedrich W., Klein, Bernard
Publicado em 2006